The phenomenon of mutual aggravation of COVID-19 and gastroesophageal reflux disease with laryngopharyngeal manifestations

The article analyzes the latest scientific data regarding the mechanism of cough as an atypical manifestation of gastroesophageal reflux disease and its relationship with cough in COVID-19. It was concluded that the combination of a patient with gastroesophageal reflux disease, especially the atypical laryngopharyngeal form, with COVID-19 causes a mutually aggravating effect and requires a balanced approach to treatment. In the absence of erosive lesions of the esophagus, it is advisable to use alginic acid drugs or antacids, as well as their combinations, as the first line of treatment for patients at the primary stage.

References

1. Zhang M.M., Chen L.N., Qian J.M. (2021) Gastrointestinal manifestations and possible mechanisms of COVID-19 in different periods. J. Digest. Dis., 22(12): 683–694. doi.org/10.1111/1751-2980.13065.
2. Gasmi A., Tippairote T., Mujawdiya P.K. et al. (2021) Neurological Involvements of SARS-CoV2 Infection. Mol. Neurobiol., 58(3): 944–949. doi.org/10.1007/s12035-020-02070-6.
3. Pan L., Mu M., Yang P. et al. (2020) Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study. Am. J. Gastroenterol., 115(5): 766–773.
4. Lin L., Jiang X., Zhang Z. et al. (2020) Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut, 69(6): 997–1001.
5. Zhang H., Kang Z., Gong H. et al. (2020) Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process. Gut, 69(6): 1010–1018.
6. Tabesh E., Soheilipour M., Sami R. et al. (2022) Gastrointestinal manifestations in patients with coronavirus disease-2019 (COVID-19): Impact on clinical outcomes. Journal of research in medical sciences. The Official J. Isfahan University of Med. Sci., 27: 32. doi.org/10.4103/jrms.jrms_641_21.
7. Han C., Duan C., Zhang S. et al. (2020) Digestive symptoms in COVID19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes. Am. J. Gastroenterol., 115: 916–923.
8. Jin X., Lian J., Hu J. (2020) Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. doi: 10.1136/gutjnl-2020-320926.
9. Kariyawasam J.C., Jayarajah U., Riza R. et al. (2021) Gastrointestinal manifestations in COVID-19. Trans. R. Soc. Trop. Med. Hyg., 115(12): 1362–1388. doi: 10.1093/trstmh/trab042. PMID: 33728439; PMCID: PMC7989191.
10. Parasa S., Desai M., Thoguluva Ch. et al. (2020) Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis. JAMA network open, 3(6): e2011335. doi.org/10.1001/jamanetworkopen.2020.11335.
11. Ramachandran P., Onukogu I., Ghanta S. et al. (2020) Gastrointestinal symptoms and outcomes in hospitalized coronavirus disease 2019 patients. Dig. Dis., 38: 373–379.
12. Tian Y., Rong L., Nian W., He Y. (2020) Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment. Pharmacol. Ther. doi: 10.1111/apt.15731.
13. Wang M.K., Yue H.Y., Cai J. et al. (2021) COVID-19 and the digestive system: A comprehensive review. World J. Clin. Cases, 9(16): 3796–3813. doi.org/10.12998/wjcc.v9.i16.3796.
14. Mishchuk V., Kupnovitska I., Gubina N. et al. (2020) Зміни з боку органів травлення в гострий період коронавірусної хвороби. Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії, 20(3): 138–142. doi.org/10.31718/2077-1096.20.3.138.
15. Xiao F., Tang M., Zheng X. et al. (2020) Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology, 158: 1831–1833.
16. Bonato G., Dioscoridi L., Mutignani M. (2020) Fecal-Oral Transmission of SARS-COV-2: Practical Implications. Gastroenterology, 159(4): 1621–1622. doi.org/10.1053/j.gastro.2020.03.066.
17. Maret-Ouda J., Markar S.R., Lagergren J. (2020) Gastroesophageal reflux disease: a review. JAMA, 324(24): 1384.
18. Barrett C.M., Patel D., Vaezi M.F. (2020) Laryngopharyngeal Reflux and Atypical Gastroesophageal Reflux Disease. Gastrointestinal endoscopy clinics of North America, 30(2): 361–376. doi.org/10.1016/j.giec.2019.12.004.
19. Sidhwa F., Moore A., Alligood E., Fisichella P.M. (2017) Diagnosis and Treatment of the Extraesophageal Manifestations of Gastroesophageal Reflux Disease. Annals of surgery, 265(1): 63–67. doi.org/10.1097/SLA.0000000000001907.
20. Lechien J.R., Saussez S., Karkos P.D. (2018) Laryngopharyngeal reflux disease: clinical presentation, diagnosis and therapeutic challenges in 2018. Current opinion in otolaryngology & head and neck surgery, 26(6): 392–402. doi.org/10.1097/MOO.0000000000000486.
21. Tauber S., Gross M., Issing W.J. (2002) Association of laryngopharyngeal symptoms with gastroesophageal reflux disease. The Laryngoscope, 112(5): 879–886. doi.org/10.1097/00005537-200205000-00019.
22. Qureshi F., Asad H., Patel P.S. et al. (2021) Gastroesophageal Reflux Disease-Associated Chronic Cough: A Population-Based Analysis of Patient Presentations in the United States. Cureus, 13(8): e17512. doi.org/10.7759/cureus.17512.
23. Javorkova N., Varechova S., Pecova R. et al. (2008) Acidification of the oesophagus acutely increases the cough sensitivity in patients with gastro-oesophageal reflux and chronic cough. Neurogastroenterol. Motil., 20: 119–124.
24. Barrett C.M., Patel D., Vaezi M.F. (2020) Laryngopharyngeal Reflux and Atypical Gastroesophageal Reflux Disease. Gastrointestinal endoscopy clinics of North America, 30(2): 361–376. doi.org/10.1016/j.giec.2019.12.004.
25. Morice A.H. (2010) The cough hypersensitivity syndrome: a novel paradigm for understanding cough. Lung, 188(Suppl. 1): S87–S90. doi: 10.1007/s00408-009-9185-z.
26. Yamasaki T., Fass R. (2017) Reflux hypersensitivity: a new functional esophageal disorder. J. Neurogastroenterol. Motil., 23: 495–503. doi: 10.5056/jnm17097.
27. Kahrilas P.J., Smith J.A., Dicpinigaitis P.V. (2014) A causal relationship between cough and gastroesophageal reflux disease (GERD) has been established: a pro/con debate. Lung, 192: 39–46.
28. Smith J.A., Decalmer S., Kelsall A. et al. (2010) Acoustic cough-reflux associations in chronic cough: potential triggers and mechanisms. Gastroenterology, 139: 754–762.
29. Ford A.C., Forman D., Moayyedi P., Morice A.H. (2006) Cough in the community: a cross sectional survey and the relationship to gastrointestinal symptoms. Thorax, 61(11): 975–979. doi.org/10.1136/thx.2006.060087.
30. Poe R.H., Kallay M.C. (2003) Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest, 123(3): 679–684. doi.org/10.1378/chest.123.3.679.
31. Kurokawa R., Kanemitsu Y., Fukumitsu K. et al. (2021) The diagnostic utility of the frequency scale for the symptoms of gastroesophageal reflux disease questionnaire (FSSG) for patients with subacute/chronic cough. The Journal of asthma: official journal of the Association for the Care of Asthma, 58(11): 1502–1511. doi.org/10.1080/02770903.2020.1805750.
32. Li X., Lin S., Wang Z. et al. (2019) Gastroesophageal reflux disease and chronic cough: A possible mechanism elucidated by ambulatory pH-impedance-pressure monitoring. Neurogastroenterology and motility: the official journal of the European Gastrointestinal Motility Society, 31(12): e13707. doi.org/10.1111/nmo.13707.
33. Rouev P., Chakarski I., Doskov D. et al. (2005) Laryngopharyngeal symptoms and gastroesophageal reflux disease. Journal of voice: official journal of the Voice Foundation, 19(3): 476–480. doi.org/10.1016/j.jvoice.2004.07.008.
34. Hammer H.F. (2009) Reflux-associated laryngitis and laryngopharyngeal reflux: a gastroenterologist’s point of view. Digestive diseases (Basel, Switzerland), 27(1): 14–17. doi.org/10.1159/000210098.
35. de Bortoli N., Nacci A., Savarino E. et al. (2012) How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J. Gastroenterol., 18(32): 4363–4370. doi.org/10.3748/wjg.v18.i32.4363.
36. Katzka D.A., Pandolfino J.E., Kahrilas P.J. (2020) Phenotypes of Gastroesophageal Reflux Disease: Where Rome, Lyon, and Montreal Meet. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association, 18(4): 767–776. doi.org/10.1016/j.cgh.2019.07.015.
37. Mahoney L.B., Rosen R. (2019) The Spectrum of Reflux Phenotypes. Gastroenterology & hepatology, 15(12): 646–654.
38. Ribolsi M., Giordano A., Guarino M.P.L. et al. (2019) New classifications of gastroesophageal reflux disease: an improvement for patient management? Expert Rev. Gastroenterol. Hepatol., 13(8): 761–769. doi: 10.1080/17474124.2019.1645596.
39. Takeda N., Takemura M., Kanemitsu Y. et al. (2020) Effect of anti-reflux treatment on gastroesophageal reflux-associated chronic cough: Implications of neurogenic and neutrophilic inflammation. The Journal of asthma: official journal of the Association for the Care of Asthma, 57(11): 1202–1210. doi.org/10.1080/02770903.2019.1641204.
40. Mandel K.G., Daggy B.P., Brodie D.A., Jacoby H.I. (2000) Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Aliment. Pharmacol Ther., 14: 669–690. doi: 10.1046/j.1365-2036.2000.00759.x.
41. Kahrilas P.J., McColl K., Fox M. et al. (2013) The acid pocket: a target for treatment in reflux disease? Am. J. Gastroenterol., 108: 1058–1064. doi: 10.1038/ajg.2013.132.
42. Kwiatek M.A., Roman S., Fareeduddin A. et al. (2011) An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial ‘acid pocket’ in symptomatic GERD patients. Aliment. Pharmacol. Ther., 34: 59–66. doi: 10.1111/j.1365-2036.2011.04678.x.
43. Leiman D.A., Riff B.P., Morgan S. et al. (2017) Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis. Diseases of the esophagus: official journal of the International Society for Diseases of the Esophagus, 30(5): 1–9. doi.org/10.1093/dote/dow020.
44. Fock K.M., Talley N., Goh K.L. et al. (2016) Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett’s oesophagus. Gut, 65: 1402–1415. doi: 10.1136/gutjnl-2016-311715.
45. Leiman D.A., Riff B.P., Morgan S. et al. (2017) Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis. Dis. Esophagus, 30: 1–9. doi: 10.1093/dote/dow020.
46. Jung H.K., Tae C.H., Song K.H. et al.; Korean Society of Neurogastroenterology and Motility (2021) 2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease. J. Neurogastroenterol. Motil., 27(4): 453–481. doi: 10.5056/jnm21077.
47. Goh K.L., Lee Y.Y., Leelakusolvong S. et al. (2021) Consensus statements and recommendations on the management of mild-to-moderate gastroesophageal reflux disease in the Southeast Asian region. JGH open : an open access journal of gastroenterology and hepatology, 5(8): 855–863. doi.org/10.1002/jgh3.12602.
48. Wilkie M.D., Fraser H.M., Raja H. (2018) Gaviscon® Advance alone versus co-prescription of Gaviscon® Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux. European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology — Head and Neck Surgery, 275(10): 2515–2521. doi.org/10.1007/s00405-018-5079-0.
49. Ciprandi G., Damiani V., Passali F.M. et al. (2021) Magnesium alginate in patients with laryngopharyngeal reflux. Journal of biological regulators and homeostatic agents, 35(1 Suppl. 2): 61–64. doi.org/10.23812/21-1supp2-12.
50. Pizzorni N., Ambrogi F., Eplite A. et al. (2022) Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial. European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology — Head and Neck Surgery, 279(5): 2533–2542. doi.org/10.1007/s00405-021-07219-0.